Amicogen, Inc. (KOSDAQ:092040)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,715.00
+12.00 (0.70%)
Jan 29, 2026, 3:30 PM KST

Amicogen Revenue

Amicogen had revenue of 10.14B KRW in the quarter ending September 30, 2025, a decrease of -74.58%. This brings the company's revenue in the last twelve months to 87.97B, down -43.52% year-over-year. In the year 2024, Amicogen had annual revenue of 173.60B with 8.57% growth.

Revenue (ttm)
87.97B
Revenue Growth
-43.52%
P/S Ratio
1.08
Revenue / Employee
372.74M
Employees
236
Market Cap
95.23B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024173.60B13.70B8.57%
Dec 31, 2023159.90B15.61B10.82%
Dec 31, 2022144.30B19.41B15.55%
Dec 31, 2021124.88B9.02B7.79%
Dec 31, 2020115.86B675.18M0.59%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EASY BIO,Inc.465.24B
Macrogen179.98B
ORIENT BIO59.09B
GeneOne Life Science30.90B
CG Invites18.12B
ENCell5.91B
Genexine5.81B
iNtRON Biotechnology5.56B
Revenue Rankings